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The budding of the urogenital sinus epithelium into the surrounding mesenchyme signals the onset of prostate
morphogenesis. The epithelial and mesenchymal factors that regulate ductal budding and the ensuing process of ductal
growth and branching are not fully known. We provide evidence that bone morphogenetic protein 4 (BMP4) is a
mesenchymal factor that regulates ductal morphogenesis. The Bmp4 gene was most highly expressed in the male urogenital
sinus from embryonic day 14 through birth, a period marked by formation of main prostatic ducts and initiation of ductal
branching. From an initial wide distribution throughout the prostatic anlage of the urogenital sinus, Bmp4 expression
became progressively restricted to the mesenchyme immediately surrounding the nascent prostatic ducts and branches.
Exogenous BMP4 inhibited epithelial cell proliferation and exhibited a dose-dependent inhibition of ductal budding in
urogenital sinus tissues cultured in vitro. Adult Bmp4 haploinsufficient mice exhibited an increased number of duct tips in
both the ventral prostate and coagulating gland. Taken together, our data indicate that BMP4 is a urogenital sinus
mesenchymal factor that restricts prostate ductal budding and branching morphogenesis. © 2001 Academic Press
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The accessory male sex organs include both Wolffian
duct derivatives (epididymis, ductus deferens, ampullary
gland, and seminal vesicle) and urogenital sinus derivatives
(prostate and bulbourethral gland). The adult mouse pros-
tate is an exocrine gland comprised of three paired lobes:
anterior (also called the coagulating gland), dorsal, and
ventral. Each lobe consists of a highly branched ductal
network connected to the urethral lumen by multiple main
ducts (Cunha and Lung, 1979; Cunha et al., 1987).
The embryonic precursor of the prostate, the prostatic
anlage, develops from the cranial portion of the urogenital
sinus and consists of a multilayered epithelium surrounded
by mesenchyme (Cunha and Lung, 1979). The first morpho-
logical change indicative of prostate development occurs
with outgrowths of the urogenital sinus epithelium into the
surrounding mesenchyme to form epithelial buds that will
1 To whom correspondence should be addressed. Fax: (312) 908-
E7275. E-mail: w-bushman@northwestern.edu.
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All rights of reproduction in any form reserved.ecome the main prostatic ducts. In the mouse, prostatic
ud formation begins at embryonic day 17 (E17: 20-day
estation period) and continues throughout the perinatal
eriod (Cunha et al., 1987). Elongation and branching of the
ain ducts begin prenatally but occur most intensively
uring the first 15 days of postnatal life (Sugimura et al.,
986). Differences in temporal and spatial patterns of ductal
ranching produce the distinctive ductal architectures that
haracterize the three prostate lobes (Lung and Cunha,
981; Sugimura et al., 1986).
Prostate development requires testosterone. Androgens
ind receptors in the urogenital sinus mesenchyme and are
ostulated to induce ductal morphogenesis by promoting
esenchymal–epithelial interactions (Cunha et al., 1987).
everal growth factors have been proposed as regulators of
rostate development. Epidermal growth factor (EGF) and
transforming growth factor-a (TGF-a) are both expressed in
odent prostate (Haughney et al., 1998) and TGF-a overex-
pression causes hyperplasia of the adult coagulating gland
(Sandgren et al., 1990), but there is no evidence that eitherGF or TGF-a are required for prostate development. Ker-
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302 Lamm et al.atinocyte growth factor (Kgf, also known as Fgf7) is ex-
pressed in the urogenital mesenchyme (Finch et al., 1995;
homson et al., 1997). KGF stimulates proliferation of
rostatic cells (Yan et al., 1992), promotes prostatic branch-
ng in vitro (Sugimura et al., 1996; Thomson et al., 1997),
and causes prostate hyperplasia when overexpressed in
transgenic mice (Kitsberg and Leder, 1996). However, trans-
genic loss of KGF function does not cause morphological
abnormalities in the reproductive tract of the adult male
(Guo et al., 1996). Fibroblast growth factor 10 (Fgf10) is
expressed in the urogenital mesenchyme and FGF10 stimu-
lates growth and branching of neonatal ventral prostate in
vitro in the absence of testosterone (Thomson and Cunha,
1999). Transforming growth factor-b1 (TGF-b1) is expressed
in the developing prostate (Timme et al., 1994; Itoh et al.,
1998). TGF-b1 inhibits proliferation of prostatic cells in
itro (Martikainen et al., 1990; Wilding, 1991) and inhibits
estosterone’s stimulatory effect on prostatic ductal mor-
hogenesis in vitro (Itoh et al., 1998).
Bone morphogenetic protein 4 (Bmp4) is a member of the
GF-b superfamily (Wozney et al., 1988) and is the verte-
rate homolog of the Drosophila gene decapentaplegic
Gelbart, 1989). Bmp4 transcripts are found in regions of the
eveloping limb, lung, kidney, whisker follicle, and tooth
ud where inductive interactions occur between mesen-
hyme and adjacent epithelium, and BMP4 has been impli-
ated in the morphogenesis of these organ systems (Bitgood
nd McMahon, 1995; Hogan, 1996). A regulatory role for
MP4 in developmental systems that involve budding and
ranching morphogenesis has received particular attention.
MP4 disrupted branching morphogenesis in embryonic
ung and kidney (Bellusci et al., 1996; Raatikainen-Ahokas
t al., 2000). The expression of Bmp4 was recently reported
in adult human, rat, and mouse prostate (Harris et al., 1994;
Thomas et al., 1998) but the role of BMP4 in prostatic bud
formation and branching has not been previously investi-
gated.
In this study, we show a dynamic pattern of Bmp4
expression in the embryonic prostate that shifts from an
initial wide domain in the prostatic anlage of the urogenital
sinus to a restricted zone of mesenchyme immediately
surrounding the emerging prostatic epithelial buds. Using a
combination of in vitro culture of embryonic urogenital
sinus tissues and quantitative analysis of the prostatic
ductal network of a previously generated Bmp4 haploinsuf-
ficient mutant mouse (Dunn et al., 1997), we demonstrate
that BMP4 inhibits epithelial cell proliferation in the uro-
genital sinus and provide evidence that in the developing
prostate BMP4 functions to restrict prostatic ductal bud-
ding and inhibit ductal branching.
MATERIALS AND METHODS
Tissue Collection
Urogenital sinus and prostate tissues were obtained from either
BALB/c (Jackson Laboratories, Bar Harbor, ME) or CD-1 (Charles
Copyright © 2001 by Academic Press. All rightRiver Laboratories, Wilmington, MA) mice. The day of vaginal plug
was designated embryonic day 0 (E0) and the day of birth was
designated P1. Adult C57BL/6J-Aw-J-Ta6J1/1ArTfm mice with mu-
ant androgen receptors (Tfm, testicular feminization) and C57BL/
-Bmp4tm1Blh mice were obtained from Jackson Laboratories. Tis-
sues were dissected as previously described (Oefelein et al., 1996;
Podlasek et al., 1997). Separation of epithelial and mesenchymal
tissues from intact E16 urogenital sinus was performed as described
previously (Cunha and Donjacour, 1987).
RNA Isolation and RT-PCR
Total RNA was isolated from either pooled or individual speci-
mens using the TRIzol method (Life Technologies, Gaithersburg,
MD) as described previously (Podlasek et al., 1997). Semiquantita-
tive RT-PCR was performed with 29 or 32 cycles of amplification
(RT-PCR Core Kit; Perkin–Elmer, Foster City, CA). Reactions were
routinely performed without reverse transcriptase to demonstrate
RNA dependence of reaction products. Quantitative RT-PCR
(QRT-PCR) was performed by determining the ratio between the
products for Bmp4 and for ribosomal subunit RPL-19 that was used
as an endogenous internal standard. RT-PCR was performed over a
range of cycle number (22–32 cycles) on 50 ng of total RNA as
described previously (Podlasek et al., 1999a,c). Densitometry of the
photographed gel was performed using the Bio-Rad Molecular
Analyst (Bio-Rad, Richmond, CA). The log of band density versus
cycle number was plotted and the ratio of the products within the
linear range was determined. RPL-19 yields a 556-bp product. Bmp4
yields a 235-bp product that was confirmed by restriction digestion
with two enzymes SacI and ApaI. Shh yields a 260-bp product that
was confirmed by restriction digestion with MspI and HaeIII.
BMPR-IA yields a 233-bp product that was confirmed by restriction
digestion with PvuII and NcoI. BMPR-IB yields a 292-bp product
that was confirmed by restriction digestion with AvaI and SacI.
RT-PCR primer sequences 59–39 were: Bmp4 antisense, TCCAG-
GAACCATTTCTGCTG; Bmp4 sense, CACTGTGAGGAGTT-
TCCATC; Bmp2 antisense, TGAGTGCCTGCGGTACAGAT;
Bmp2 sense, TGTCTTCTAGTGTTGCTGCT; RPL-19 antisense,
GGAAGAGTCTTGATGATCTC; RPL-19 sense, CTCAGGCTA-
CAGAAGAGGCTT; Shh antisense, ACTGCTCGACCCTCAT-
AGTG; Shh sense, GGCAGATATGAAGGGAAGAT; BMPR-1A
antisense, GGTTGTGCTCATTTCCATGG; BMPR-1A sense, TG-
GCAATAGTTCGCTGAACC; BMPR-1B antisense, TAGCGGC-
CTTTTCCAATCTG; BMPR-1B sense, TTGTTGATGGGC-
CCATACAC.
Probe Synthesis
A full-length (1550-bp) Bmp4 cDNA cloned into pSP72 was
provided by Dr. Hogan (Vanderbilt University Medical Center,
Nashville, TN). The CsCl-purified plasmid was linearized with
AccI (antisense) and EcoRV (sense). Probes were prepared using a
DIG RNA labeling kit (Roche Molecular Biochemicals, Indianapo-
lis, IN) and appropriate T7 and SP6 RNA polymerases. Concentra-
tions of antisense and sense riboprobes, quantitated by spotting
dilutions on nitrocellulose paper along with control DIG-RNA,
were about 2 mg/ml.
Whole-Mount in Situ Hybridization
In situ hybridization of 4% paraformaldehyde-fixed urogenital
tissues was performed according to a previously described protocol
s of reproduction in any form reserved.
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303BMP4 Regulates Prostate Ductal Development(Wilkinson, 1992). Briefly, tissues were bleached with 6% hydrogen
peroxide (60 min), digested with 10 mg/ml proteinase K (15 min),
nd refixed in 0.2% glutaraldehyde/4% paraformaldehyde (20 min)
t room temperature. Hybridization with digoxygenin-labeled
NA probes for Bmp4 (1 mg/ml) was performed at 70°C for 16 h.
ollowing high stringency washes and RNAse treatment, tissues
ere incubated with an alkaline phosphatase-coupled anti-
igoxygenin antibody (Roche Molecular Biochemicals) for 16 h at
°C. The color reaction was developed using nitroblue tetrazolium
nd 5-bromo-4-chloro-3-indolyl phosphate as substrates. Some
tained tissues were incubated in 50% sucrose/phosphate buffered
aline (PBS) solution at 4°C overnight, embedded in Tissue-Tek
CT compound and cryosectioned at 15 mm.
In Vitro Organ Culture
Culture of male urogenital sinus obtained at E15 and E17 was
performed as previously described (Cooke et al., 1987). Tissues
ere isolated from the bladder, distal urethra, and Wolffian and
ullerian ducts and transferred to 0.4 mm Millicell-CM filters
(Millipore Corp., Bedford, MA) placed inside six-well tissue plates.
Each well contained 1.5 ml serum-free DMEM:Ham’s F-12 (1:1)
supplemented with 2% ITS (12.5 mg/ml insulin, 12.5 mg/ml trans-
ferrin, 12.5 ng/ml selenious acid, 2.5 mg/ml bovine serum albumin,
and 10.7 mg/ml linoleic acid; Collaborative Biomedical Products,
edford, MA), 25 mg/ml gentamycin, 0.25 mg/ml amphotericin B,
nd 1028 M dihydrotestosterone (DHT) dissolved in 95% ethanol.
In DHT-free media, ethanol was added to a final concentration of
0.1%. Cultures were maintained in a humidified 37°C, 5% CO2
incubator.
BMP4 Bead Experiments on Cell Proliferation
Recombinant human (rh) BMP4 protein was supplied by Genet-
ics Institute (Cambridge, MA). Agarose beads (100–200 mm diam-
ter; Bio-Rad) were incubated in BMP4 solution (37.5 mg/ml) or PBS
for 1 h at room temperature. One to four beads were placed on each
urogenital sinus at the mesenchymal–epithelial interface of the
prostatic anlage. Tissues were maintained in serum-free, DHT-
supplemented culture medium as described above. Following 48 h
of culture, bromodeoxyuridine (BrdU) staining of tissues was per-
formed using an in situ proliferation kit according to the manufac-
turer’s protocol (Roche Molecular Biochemicals). BrdU uptake in
formalin-fixed sectioned tissues was visualized following incuba-
tion with anti-BrdU-alkaline phosphatase-conjugated antibody. For
quantitative analysis of BrdU staining, all fields containing BMP4
or control beads were examined under one high-power field at 340
magnification within an area of 1.4 mm2 with the bead in the
enter of the field. Stained epithelial and mesenchymal cells within
his area were counted and BrdU labeling indices (number of
tained nuclei/total number of nuclei counted 5 % labeled) were
etermined. The proportions of stained nuclei in control and
MP4-treated sections were analyzed using chi-square test. Adja-
ent sections were processed for TUNEL staining to detect cell
eath using the in situ apoptosis detection kit according to the
anufacturer’s directions (Trevigen Inc., Gaithersburg, MD).
Morphologic Analysis of Heterozygous Bmp4
Mutant Mice
Construction of the targeting vector and generation of chimeras
and colonies of mice heterozygous for the Bmp4tm1Blh targeted allele n
Copyright © 2001 by Academic Press. All rightas previously described (Winnier et al., 1995). Adult heterozygous
Bmp4tm1Blh mutants and wildtype (C57BL/6J) animals were obtained
from Jackson Laboratories. Qualitative and quantitative analyses of
main ducts (n 5 5 wildtype and 5 mutant mice) and duct tips (n 5
wildtype and 10 mutant mice) in prostatic lobes were performed
n a blinded manner as previously described (Podlasek et al., 1997).
Quantitative microdissection of individual prostatic lobes and
counting of the duct tips as a measure of ductal branching were
performed as previously described (Sugimura et al., 1986; Podlasek
et al., 1997). Statistical analysis of differences was performed using
unpaired t test.
RESULTS
Bmp4 Expression during Prostate Development
The time course of Bmp4 expression in the developing
prostate was determined by QRT-PCR (Fig. 1). Bmp4 ex-
pression was generally high in the urogenital sinus from
E14 through P1. Expression significantly decreased in the
postnatal period (P5, P10) and declined to an even lower
level in the adult. The overall level of Bmp4 expression in
the coagulating gland, ventral prostate, and dorsal prostate
was compared by QRT-PCR at P5, the earliest time point at
which the different lobes can be cleanly separated. The
level of Bmp4 expression was similar in all three lobes (data
FIG. 1. Time course of Bmp4 expression in the urogenital sinus
nd developing prostate as determined by QRT-PCR utilizing the
essage for ribosomal subunit RPL-19 as an internal standard.
Each bar represents the mean 6 SEM of triplicate assays of RNA
from pooled tissues at each time point. Figure inset shows time
course of Bmp2 expression determined by QRT-PCR at the same
ime points as that used for Bmp4. A comparison of Bmp2 and
mp4 expression was made by using the same internal standard for
oth reactions and normalizing Bmp2 expression to the expression
f Bmp4 at E18. Each bar represents the mean 6 SEM of duplicate
ssays of RNA from pooled tissues at each time point.ot shown). The Bmp4 homolog Bmp2 is also expressed in
s of reproduction in any form reserved.
304 Lamm et al.FIG. 2. Localization of Bmp4 expression in the male urogenital sinus and developing prostate by whole-mount in situ hybridization. (A)
A broad distribution of staining (dark purple) for Bmp4 message in the urogenital sinus at E17 is evident. Arrows demarcate the caudal
boundary of Bmp4 expression with the adjacent urethra (u). (B) At E19, the domain of Bmp4 expression in the urogenital sinus is punctuated
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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305BMP4 Regulates Prostate Ductal DevelopmentFIG. 4. Bmp4 expression in the urogenital sinus is not androgen-dependent. (A) At E18, staining for Bmp4 message is seen throughout the
urogenital sinus (ugs) and the urethra (u) of the female lower urogenital tract. At P1, diffuse Bmp4 expression persists in the urogenital sinus
region caudal to the uterus (ut). ov, oviduct; b, bladder. (B) QRT-PCR for Bmp4 expression in male urogenital sinus tissues obtained at E15
and cultured for 72 h in the presence or absence of 1028 M DHT. Each bar represents the mean 6 SEM of triplicate assays of RNA from
pooled samples (n 5 4 tissues). (C) QRT-PCR for Bmp4 expression in urogenital sinus tissues obtained at P1 from male C57BL/6J-Aw-J-
a6J1/1ArTfm mutant mouse with testicular feminization (Tfm) and its wildtype control (WT). Each bar represents the mean 6 SEM of
riplicate assays of RNA from individual samples. For both (B) and (C), assays were performed utilizing the message for ribosomal subunit
PL-19 as an internal standard. Please note that higher Bmp4/RPL-19 product ratios in these experiments compared to those of Fig. 1 werehe result of using a newly synthesized set of Bmp4 primers which yielded a higher efficiency reaction than that of the RPL-19 standard.by circular areas with little or no apparent staining for Bmp4 message. (C) Bmp4 expression is concentrated around the emerging prostatic
main ducts at P1. Ducts of both the dorsal prostate (dp) and ventral prostate (vp) are ringed with staining for Bmp4 message and their
“punched out” appearance is evident. Staining also outlines the main ducts of the coagulating gland (cg). The sketches on the bottom panels
illustrate the gross morphological changes in the male lower urogenital tract as the prostate develops from its anlage in the urogenital sinus
(ugs) prior to onset of prostatic budding at E17 to the early appearance of prostatic ductal buds in the coagulating gland (cg), dorsal prostate
(dp), and ventral prostate (vp) at P1. b, bladder; u, urethra; dp, dorsal prostate; vp, ventral prostate; cg, coagulating gland; t, testis; ur, ureter;
ugs, urogenital sinus; sv, seminal vesicle. Scale bar 5 100 mm. Data are representative of at least two animals per time point analyzed.
FIG. 3. Mesenchymal distribution of Bmp4 expression in sections of P1 whole-mount in situ hybridization specimens. (A) Cross section
f a prostatic duct reveals Bmp4 expression (arrowhead) surrounding the ductal bud as suggested by “punched out” appearance of the
hole-mount in situ specimens (see Fig. 2C). (B) Bmp4 expression is concentrated in and restricted to the mesenchyme (m) surrounding the
rostatic bud epithelium (e). (C) Staining for Bmp4 expression is intense in mesenchyme separating prostatic buds (arrows). The staining
or Bmp4 expression in the mesenchyme around apical ends of ducts cut in longitudinal section (arrowheads) varied from strong (B) to
elatively light (C). Section of a main duct (D) branching into two lateral buds (asterisks) shows Bmp4 expression is concentrated in the
eriductal mesenchyme proximal to the branch point (arrows) and also in the mesnchyme separating the nascent branches (arrowhead). The
xis of the duct proximal to the branch point, determined by examination of adjacent sections (not shown), is delineated by dotted lines.
o apparent staining for Bmp4 in the epithelium (e) is evident in any of the sections examined. The mesenchymal and epithelial
esignations were confirmed by immunostaining for the mesenchyme-specific marker vimentin (not shown). Scale bar 5 20 mm for (A)–(C);
10 mm for (D).
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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306 Lamm et al.the developing prostate, but the expression is relatively low
(Fig. 1, inset). QRT-PCR analysis of the time course of
Bmp2 expression revealed maximal expression at E18 with
comparable expression in all three prostate lobes at P5 (data
not shown).
Localization of Bmp4 message by whole-mount in situ
ybridization revealed a changing distribution of Bmp4
xpression in the developing prostate. Bmp4 message was
nitially localized to a broad and apparently uniform expres-
ion domain encompassing the prostatic anlage of the male
rogenital sinus at E15 (data not shown) and E17 (Fig. 2A).
clear inferior boundary of Bmp4 expression corresponded
o the caudal margin of the prostatic anlage and demarcated
he junction with the adjacent urethra (Fig. 2A, denoted
ith arrows). The specificity of staining for Bmp4 expres-
ion was evidenced by lack of staining when a sense probe
or Bmp4 was used (data not shown). Later in development
E19), the homogeneous distribution of Bmp4 expression in
he urogenital sinus was punctuated by circular areas with
“punched out” appearance that seemed to reflect little or
o staining for Bmp4 message. These “punched out” circles
ppeared only in the region of the urogenital sinus where
uctal budding occurs (Fig. 2B). As prostatic main buds
ppeared in distinct clusters forming the dorsal prostate,
entral prostate, and coagulating gland at P1, Bmp4 expres-
ion was cleared from most of the urogenital sinus but
emained highly concentrated around the nascent ducts
Fig. 2C). Staining for Bmp4 expression at P5 outlined the
developing main ducts and branches of the coagulating
gland, dorsal prostate, and ventral prostate (data not
shown).
Sectioning of P1 whole-mount specimens showed that
Bmp4 expression was most abundant in the mesenchyme
immediately surrounding the epithelial buds (Figs. 3A–3D).
Expression was localized very strongly in the mesenchyme
separating adjacent buds (Fig. 3C). Sections of a main duct
branching into two lateral buds (Fig. 3D) revealed concen-
trated staining for Bmp4 expression in the periductal mes-
enchyme proximal to the branch point (arrows) and in the
mesenchyme separating the two nascent branches (arrow-
head). No epithelial staining for Bmp4 expression was
observed at any of the time points analyzed. This finding is
in agreement with our previous demonstration by RT-PCR
that Bmp4 expression in the E16 male urogenital sinus is
confined strictly to the mesenchyme (Podlasek et al.,
1999c).
Bmp4 Expression Is Not Androgen-Dependent
Because prostate development is unique to the male, we
examined whether Bmp4 expression was dependent on
testosterone. Whole-mount in situ hybridization of E18
female lower urogenital tract revealed a wide domain of
Bmp4 expression in the urogenital sinus (Fig. 4A) compa-
rable to that in the E17 male (Fig. 2A). At P1, however,
Bmp4 expression remained diffusely distributed in the
urogenital sinus region caudal to the uterus without the c
Copyright © 2001 by Academic Press. All rightpunched out” areas evident in the P1 male (compare Fig.
A, P1 with Fig. 2C). To test directly the androgen depen-
ence of Bmp4 expression, male urogenital sinus tissues
ere obtained at E15 and cultured for 72 h in the presence
r absence of 1028 M dihydrotestosterone (DHT). QRT-PCR
analysis showed comparable levels of Bmp4 expression (Fig.
4B). Similarly, no significant difference in level of expres-
sion was observed when tissues were harvested at E18 and
cultured for 72 h in the presence or absence of DHT (data
not shown). Because testosterone secretion in the male
begins prior to E15 (Cunha, 1973), we considered the
possibility that earlier exposure to androgen might program
Bmp4 expression in the prostatic anlage. To address this
issue, we compared Bmp4 expression in male mice with
mutant androgen receptors (testicular feminization: Tfm)
and their wildtype controls. The Tfm is a frameshift muta-
tion of the androgen receptor that renders the males insen-
sitive to androgens (Charest et al., 1991). Assay for Bmp4
expression by QRT-PCR in the P1 urogenital sinus of Tfm
mice and their wildtype controls (i.e., same strain back-
ground as that of Tfm mice) showed minimal difference in
expression (Fig. 4C). These data indicate that Bmp4 expres-
sion in the developing prostate is not testosterone-
dependent.
BMP4 Inhibits Prostate Epithelial Proliferation
The biological effect of BMP4 is mediated by binding to a
membrane-bound heterodimer receptor composed of a BMP
type II receptor (BMPR-II) complexed with either of two
type I receptors, BMPR-IA or BMPR-IB (Yamashita et al.,
1996). To determine which of the ligand-binding type I
receptors were expressed in the developing prostate, semi-
quantitative RT-PCR on RNA from separated epithelium
and mesenchyme of E16 urogenital sinus was performed
using primers specific to BMPR-IA and BMPR-IB. We
reviously used this technique of tissue separation to dem-
nstrate the specificity of Shh and Bmp4 expression in the
pithelium and mesenchyme, respectively (Podlasek et al.,
999a,c). As shown in Fig. 5, both BMPR-IA (lane 1) and
MPR-IB (lane 2) were expressed in the separated urogenital
inus mesenchyme (UGM). Control reactions performed
ith primers for the mesenchymal marker Bmp4 (lane 3)
nd the epithelial marker Shh (lane 4) confirmed the purity
f the mesenchymal sample. Expression of BMPR-IA (lane
) and BMPR-IB (lane 6) was also detected in the separated
rogenital sinus epithelium (UGE). When control reactions
ere performed with primers for Bmp4 (lane 7) and Shh
lane 8) to check the purity of the epithelial preparation, a
aint Bmp4 product band was observed. Identical results
ere obtained with three different preparations of separated
pithelium. This could reflect either low-level Bmp4 ex-
ression in the epithelium or slight mesenchymal contami-
ation of the epithelial preparation. In either case, the
mp4 product band is extremely faint. The BMPR-IA and
MPR-IB product bands are strong by contrast and are
onsistent with expression of both receptors in the UGE.
s of reproduction in any form reserved.
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307BMP4 Regulates Prostate Ductal DevelopmentTo determine the effect of BMP4 on cell proliferation in
the developing prostate, we examined the effect of exog-
enous BMP4 on epithelial and mesenchymal proliferation
in urogenital sinus cultured in vitro. Affi-Gel beads soaked
in either BMP4 (37.5 mg/ml in PBS) or PBS alone were
implanted onto the prostatic anlagen of E17 urogenital
sinus. Following 48 h of culture in serum-free, DHT-
supplemented media (conditions sufficient to support duc-
tal branching in the developing prostate; see below), BrdU
incorporation in BMP4-treated and control tissues was
quantitated by examining representative sections under
340 magnification with the bead in the center of the field.
Stained epithelial and mesenchymal cells within the area of
one high-power field surrounding the bead (1.4 mm2) were
counted and BrdU-labeling indices (number of stained
nuclei/total number of nuclei counted 5 % labeled) were
determined. Control sections revealed a labeling index of
8.5% and 2.9% in the epithelium and mesenchyme, respec-
tively (Table 1). BMP4 treatment significantly decreased the
labeling index in the epithelium from 8.5% to 2.8% (P ,
0.0001) without affecting that in the mesenchyme (Table 1).
These data indicate a selective inhibitory effect of BMP4 on
epithelial proliferation in the developing prostate.
BMP4 has been shown to induce apoptosis in several
tissues (Graham et al., 1994; Ganan et al., 1996; Bellusci et
al., 1996; Jernvall et al., 1998; Raatikainen-Ahokas et al.,
2000). To determine whether apoptosis contributed to the
reduced epithelial cell proliferation index in BMP4-treated
tissues, sections adjacent to those used for BrdU studies
were analyzed by the TUNEL technique. Staining of control
sections revealed an extremely low incidence of TUNEL-
labeled cells in both the epithelial and mesenchymal com-
partments. Comparison of TUNEL staining in sections of
FIG. 5. Semiquantitative RT-PCR for expression of BMP type I
receptors in separated E16 urogenital mesenchyme (UGM) and
urogenital epithelium (UGE). Assay was performed on RNA from
pooled tissues (n 5 5–6 tissues) using primers for both RPL-19 (as
internal standard; denoted with arrow) and either BMPR-IA (lanes
1 and 5: 233 bp), BMPR-IB (lanes 2 and 6: 292 bp), Bmp4 (lanes 3 and
7: 235 bp), or Shh (lanes 4 and 8: 260 bp). BMPR-IA and BMPR-IB
message are expressed in both UGM and UGE. Bmp4 and Shh
messages were assayed to determine quality of epithelial–
mesenchymal separation. Faint Bmp4 product band in lane 7
suggests slight mesenchymal contamination of the UGE. Reactions
performed in parallel without reverse transcriptase demonstrated
the RNA dependence of the reaction products (data not shown).BMP4-treated and control tissues did not suggest any in- u
Copyright © 2001 by Academic Press. All rightcrease in TUNEL staining in the vicinity of the BMP4-
soaked beads (data not shown). Sections of prostate from an
adult animal 3 days postcastration stained in parallel
showed abundant TUNEL staining, verifying the sensitivity
of the assay (data not shown). These observations suggest
that exogenous BMP4 at the concentrations used does not
cause apoptosis in either the mesenchyme or epithelium of
the developing prostate.
BMP4 Inhibits Prostate Ductal Budding
BMP4 has been identified as a regulator of branching
morphogenesis in the developing lung and kidney (Bellusci
et al., 1996; Raatikainen-Ahokas et al., 2000; Miyazaki et
l., 2000). To determine whether BMP4 influenced prostate
uctal budding, E15 male urogenital sinus tissues were
aintained in serum-free, DHT-supplemented media in the
bsence or presence of exogenous BMP4 (30 or 300 ng/ml).
ollowing 6 days of culture, all control prostate rudiments
ad grown in size and displayed extensive prostate ductal
udding (compare Figs. 6A and 6B). The prostatic buds
xtended from the cranial region of the urogenital sinus in
bilaterally symmetrical pattern, forming an arborlike
anopy with the urethra extending caudally (Fig. 6B). The
ucts were mostly elongate with slightly dilated apical ends
nd the beginnings of ductal branching can be discerned
Fig. 6B, denoted with arrow).
Among tissues treated with exogenous BMP4, the num-
er and/or size of ductal buds were decreased (Figs. 6C and
D). The effect was more pronounced at the higher concen-
ration of BMP4 used (300 ng/ml) where eight out of 12
67%) prostate rudiments exhibited either barely discern-
ble, stumplike outgrowths (not shown) or just a few pros-
atic buds (Fig. 6D). To quantitate morphological differ-
nces, the number of discernible ductal tips was counted
rom photographs of individual prostate rudiments taken at
he same magnification. BMP4 significantly reduced the
ean number of prostate ductal tips in a dose-dependent
anner (Fig. 6E).
TABLE 1
Effect of BMP4 on Cellular Proliferation
Tissue layer
Stained/total nuclei (labeling index)
PControl beads BMP4 beads
pithelium 630/7435 (8.5%) 229/8193 (2.8%)* ,0.0001
esenchyme 542/18,860 (2.9%) 481/18,091 (2.7%) 0.21
Note. Affi-Gel beads soaked in either PBS (Control) or BMP4
37.5 mg/ml) were implanted onto E17 male urogenital sinus
issues. Following 48 h of culture, BrdU staining of tissues was
erformed and the labeling index was determined.
*P , 0.0001 between control and BMP4-treated epithelial
abeling indices determined from 11 control and 10 BMP4-treated
rogenital sinus tissues.
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308 Lamm et al.Effect of Bmp4 Haploinsufficiency
To investigate the normal role of BMP4 in prostate
FIG. 6. Exogenous BMP4 inhibits prostate ductal budding. Male u
serum-free, testosterone-supplemented medium in the absence (B) o
in size and developed numerous buds in the urogenital sinus. Duct
or 300 ng/ml (D), prostate rudiments exhibited fewer prostatic buds
that BMP4 at 300 ng/ml significantly (*P 5 0.008) reduced the mea
prostatic tissues per treatment group. Scale bar 5 200 mm. u, uretdevelopment, we examined the effect of Bmp4 partial loss 1
Copyright © 2001 by Academic Press. All rightf function. Homozygous Bmp4 loss-of-function mutation
n the mouse is lethal between E6.5 and E9.5 (Winnier et al.,
nital sinus tissues obtained at E15 (A) were cultured for 6 days in
ence (C, D) of BMP4. (B) The control prostate rudiments had grown
nching is evident (arrow). In the presence of BMP4 at either 30 (C)
those of controls (B). (E) Quantitative analysis of budding showed
ber of ductal tips. Each bar represents the mean (6 SEM) of 11–12roge
r pres
al bra
than
n num995), a period prior to initiation of prostate development.
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309BMP4 Regulates Prostate Ductal DevelopmentHowever, the heterozygous mutants (haploinsufficient) are
viable (Dunn et al., 1997). We first confirmed by RT-PCR
analysis that the level of Bmp4 expression in the developing
rostate of mutant Bmp4 haploinsufficient mice was lower
han that in wildtype animals (Fig. 7A). The effect of Bmp4
partial loss of function on prostate ductal development was
then determined through quantitative morphologic com-
parison of prostate size and ductal architecture between
adult Bmp4 haploinsufficient animals and their wildtype
controls. No gross morphological differences were consis-
FIG. 7. Effect of Bmp4 haploinsufficiency. (A) Semiquantitative R
ient (Bmp4 1/2) and its wildtype control (WT) was performed on R
556 bp) product band intensities suggests that Bmp4 expression is lo
dult wildtype and transgenic Bmp4 1/2 mice exhibit no major
rchitecture in the adult coagulating gland (CG), ventral prostate (V
encircled) and three duct tips (*) are marked to illustrate how thetently observed among the different prostate lobes, as
Copyright © 2001 by Academic Press. All rightillustrated by a comparison of the wildtype and mutant
ventral prostate (Fig. 7B). To determine whether Bmp4
haploinsufficiency would alter the number of ductal buds
that develop into main prostatic ducts, we compared the
number of main ducts in the coagulating gland, ventral
prostate, and dorsal prostate of adult mutant and wildtype
mice. No significant differences were observed (Table 2A).
However, quantitative analysis of the ductal architecture in
the haploinsufficient mice did reveal significant increases
in the number of duct tips in the coagulating gland and
CR for Bmp4 expression in prostate of P1 Bmp4tm1Blh haploinsuffi-
from individual samples. Comparison of Bmp4 (235 bp) and RPL19
in the haploinsufficient mouse. (B) Ventral prostate lobes (VP) from
s morphological differences. (C) Schematic illustration of ductal
nd dorsal prostate (DP). In the schematic for VP, two branch points
ctal morphologic features are quantitated.T-P
NA
wer
gros
P), aventral prostate (Table 2B).
s of reproduction in any form reserved.
m
m
B
n
a
m
a
p
d
p
m
i
v
v
m
a
i
C
B
b
e
m
u
A
310 Lamm et al.The ductal architecture of prostatic lobes can be compre-
hensively examined by isolating the individual lobes and
microdissecting the tissues to expose the complete ductal
network. The number of duct tips and branch points pro-
vide a reproducible and quantitative measure of ductal
morphogenesis that can be used to assay the effect of
genetic and chemical dysregulation on ductal morphogen-
esis (Seo et al., 1997; Podlasek et al., 1997, 1999a,b). The
three prostate lobes display distinct ductal architectures
(Lung and Cunha, 1981; Sugimura et al., 1986) as illustrated
in Fig. 7C. Each coagulating gland lobe consists of two main
ducts with multiple secondary and rare tertiary branches
(Fig. 7C) (Lung and Cunha, 1981). We observed a statisti-
cally significant 23% increase in the mean number of duct
tips in the coagulating glands of Bmp4 haploinsufficient
ice (Table 2B). Our analysis also showed an increase in the
ean number of branch points in the coagulating gland of
mp4 haploinsufficient mice, although the difference did
ot reach statistical significance. In that we did not observe
ny additional main ducts in the coagulating glands of the
utant mice, the increase in duct tips can be attributed to
n increased number of branching events. Each ventral
rostate lobe consists of 1–3 main ducts that undergo a
ichotomous pattern of branching (Fig. 7C) (Sugimura et al.,
1986). We observed a statistically significant increase in
both the mean number of duct tips and branch points in the
ventral prostate of the mutants (Table 2B). Each dorsal
prostate lobe consists of multiple main ducts that branch
distally into several ducts (Fig. 7C) (Sugimura et al., 1986).
Our analysis revealed a slight increase in the mean number
of duct tips and branch points in the dorsal prostate of the
mutant animals, although the differences were not statisti-
cally significant (Table 2B). To complete the analysis of the
TABLE 2
A. Comparison of number of main ducts in prostate lobes of adul
Prostate lobe
Coagulating gland
Ventral prostate
Dorsal prostate
B. Quantitative morphologic analysis of ductal branching in prost
Prostate lobe
Wet weight (mg)
Wildtype Bmp4 mutant
Coagulating gland 25.8 (61.2) 29.8 (62.6)
Ventral prostate 13.2 (61.1) 11.0 (61.9)
Dorsal prostate 16.6 (61.1) 13.5 (61.5)
Note. Values are means 6 SEM.
*P , 0.05.prostate in the haploinsufficient animals, histologic sec- c
Copyright © 2001 by Academic Press. All righttions of the adult mutant and wildtype animals were
examined in blinded fashion. This revealed no obvious
differences in epithelial or stromal differentiation (data not
shown).
DISCUSSION
Prostatic ductal budding and branching is postulated to
result from regulated cross-talk involving stimulatory and
inhibitory signaling and transcription factors in both the
mesenchyme and epithelium. The known factors that in-
fluence prostate ductal morphogenesis are shown in Fig. 8.
We provide evidence that BMP4 is a mesenchymal factor
that restricts prostatic ductal budding and branching by
inhibiting epithelial cell proliferation. To demonstrate this
effect, we utilized in vitro culture of E15 male mouse
rostate rudiments in testosterone-supplemented media to
imic the in vivo process of prostatic budding. This 6-day
n vitro culture corresponds to the time span E15-P1 in
ivo, a period when the coagulating gland main ducts,
entral prostate main ducts, and some of the dorsal prostate
ain ducts are formed (Lung and Cunha, 1981; Sugimura et
l., 1986). In this culture system, exogenous BMP4 inhib-
ted prostatic ductal budding in a dose-dependent fashion.
ompanion studies revealed a specific inhibitory effect of
MP4 on epithelial cellular proliferation.
An inhibitory effect of BMP4 on bud formation and ductal
ranching has been demonstrated in other systems. Exog-
nous BMP4 suppressed embryonic chick feather bud for-
ation (Jung et al., 1998) and decreased the number of
reteric tips in mouse kidney rudiments (Raatikainen-
hokas et al., 2000). Ectopic misexpression of Bmp4 de-
type and heterozygous Bmp4 mutant mice.
Number of main ducts
Wildtype Bmp4 mutant
4 (60) 4 (60)
6 (60.5) 4 (60.5)
18 (62) 19 (63)
bes of adult wildtype and heterozygous Bmp4 mice.
umber of branch points Number of duct tips
type Bmp4 mutant Wildtype Bmp4 mutant
(63) 36 (66) 140 (64) 172 (611)*
(64) 73 (65)* 131 (64) 164 (611)*
(68) 107 (68) 240 (66) 247 (610)t wild
ate lo
N
Wild
30
58
102reased the number of terminal buds and inhibited epithe-
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311BMP4 Regulates Prostate Ductal Developmentlial proliferation in transgenic embryonic lung (Bellusci et
l., 1996). Similarly, misexpression of Bmp4 inhibited cel-
ular proliferation and disrupted hair follicle morphogenesis
n transgenic mice (Blessing et al., 1993). Our localization
tudies paint a dynamic pattern of Bmp4 expression in the
eveloping prostate. Prior to any morphological evidence of
udding (E17), Bmp4 is expressed widely in the urogenital
inus. Later in development, the homogeneous expression
f Bmp4 in the urogenital sinus is punctuated by circular
reas that appear to express little or no Bmp4. These
punched out” areas coincide with the region where pros-
atic ducts form and it is tempting to speculate that these
re sites of imminent bud formation. Eventually, Bmp4
xpression is restricted to a narrow region of mesenchyme
mmediately surrounding nascent epithelial buds and duc-
al branches. Our finding that exogenous BMP4 inhibits
uctal budding suggests that clearing of Bmp4 expression
rom sites of imminent bud formation relieves the restric-
ive action of BMP4 on epithelial proliferation and is a
ecessary step in bud formation.
The Bmp4 haploinsufficient mutant mouse provided an
pportunity to determine how prostate development is
ltered by partial loss of endogenous BMP4 function. Given
he inhibitory effect of exogenous BMP4 on prostate ductal
udding (present data) and the preaxial polydactyly of the
ind limb in Bmp4 heterozygous null mutants (Dunn et al.,
1997), we postulated that Bmp4 haploinsufficiency might
increase prostate size, ductal budding, and/or ductal
branching. Our analysis revealed no increase in overall
prostate size and no gross morphological changes. There
was no increase in the number of main prostatic ducts in
the coagulating gland, dorsal prostate, or ventral prostate.
This finding indicates that the number of ductal buds is not
increased by Bmp4 haploinsufficiency and suggests that
diminished Bmp4 expression is not sufficient to initiate
main duct formation. A critical role for other factors in
determining the sites of ductal budding is consistent with
our previous finding that the number of main prostatic
ducts is reduced by mutations in the Hox genes Hoxd-13
and Hoxa-13 (Podlasek et al., 1997, 1999b). On the other
and, Bmp4 haploinsufficiency does produce an increase in
uctal branching in both the coagulating gland and ventral
rostate, a result suggesting that Bmp4 plays an active role
n determining the number of branching events during
uctal morphogenesis. The distribution of Bmp4 expression
n the periductal mesenchyme and its apparent diminished
xpression at nascent branch points (Fig. 3D) suggest that
MP4 may serve to actively restrict branching and that
mp4 haploinsufficiency compromises this function.
The Bmp4 partial loss of function mutation affected
ranching morphogenesis in the ventral prostate and coagu-
ating gland more than in the dorsal prostate. The period of
igh Bmp4 expression, E14 through P1, embraces a time
hen ventral prostate main ducts form and begin to branch
Sugimura et al., 1986). The main ducts of the coagulating
land also form by P1 and ductal branches appear at P3
Lung and Cunha, 1981). This is in contrast to the dorsal r
Copyright © 2001 by Academic Press. All rightrostate, in which main duct formation begins prenatally
ut ductal branching does not occur intensively until P10
Sugimura et al., 1986), a period when Bmp4 expression is
lready on the decline. The offset in timing of ductal
ranching in the different prostate lobes may be indicative
f different molecular mechanisms that control branching.
uch prostate lobe-specific effects have been observed pre-
iously: retinoic acid administration to newborn mice in-
ibited branching in the ventral prostate more severely
han in the dorsal prostate (Seo et al., 1997). An alternate
explanation for the differential effect of Bmp4 loss-of-
function mutation on branching in the ventral prostate and
dorsal prostate would be a ventral–dorsal axis of differential
sensitivity to endogenous BMP4 action. In the developing
kidney, an anterior–posterior axis of BMP4 responsiveness
has been postulated to explain the severity of branching
deformities in the anterior versus the posterior half of the
ureteric bud in response to exogenous BMP4 (Raatikainen-
Ahokas et al., 2000).
Bmp4 has been postulated to regulate branching in the
developing lung and kidney (Bellusci et al., 1996;
Raatikainen-Ahokas et al., 2000; Miyazaki et al., 2000),
determine the spacing of developing teeth (Vainio et al.,
1993; Neubuser et al.,1997), and control the spacing of
feather primordia in chick epidermis (Jung et al., 1998;
Noramly and Morgan, 1998). The basic model for develop-
ment in these systems postulates that budding is deter-
mined by an interaction of positive growth regulators (e.g.,
members of the FGF family and Shh) and negative growth
regulators (such as BMP4 and/or BMP2) (Jung et al., 1998;
Hogan, 1999). According to this model, the negative regu-
lator modulates the response to the positive growth signal
so as to determine a discrete site of bud formation while
providing lateral inhibition to create spacing between buds.
In these other systems, Bmp4 expression is essentially
uniform over the region of the developing bud. Formation of
a bud in the center of the Bmp4 expression domain but
inhibition in the lateral domain is postulated to result from
differing balances of positive and negative growth signaling
that accrue from different diffusional properties of positive
and negative signaling molecules (Jung et al., 1998; Hogan,
1999).
The developing prostate appears to be different in two
respects. First, our studies show that Bmp4 expression is
cleared at the site of bud formation and this may provide a
focal release of growth inhibition at the apical zone to allow
for proximal–distal elongation. Second, the failure of Bmp4
haploinsuffiency to produce an increase in the number of
main ducts suggests that Bmp4 expression does not directly
determine the number and spacing of budding events. As
buds elongate, Bmp4 expression outlines the mesenchyme
long the axis of growing ducts (see Fig. 2C). Having found
hat genetic haploinsufficiency for Bmp4 produced an in-
rease in ductal branching in the coagulating gland and
entral prostate, we postulate that the canonical pattern of
mp4 expression in elongating ducts normally serves to
estrict lateral branching.
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312 Lamm et al.We previously demonstrated the expression of sonic
hedgehog (Shh) in the urogenital sinus epithelium and
howed that antibody blockade of Shh function abrogates
FIG. 8. Factors that regulate ductal budding and branching m
esenchyme is strongest immediately surrounding the prostatic b
in the urogenital sinus mesenchyme and TGF-b1 protein has been l
et al., 1994). Mice with mutation in TGF-b1 were previously reporte
hen, 2000). Fgf10 is expressed in the urogenital sinus mesenchyme
rostatic ducts. FGF10 stimulates the development of ventral pros
gf is expressed in the urogenital sinus mesenchyme, although its
Finch et al., 1995). KGF stimulates ductal branching in the absenc
xpressed in the urogenital sinus epithelium during the period of du
uctal morphogenesis (Podlasek et al., 1999a). The transcription
esenchyme and expression is upregulated by Shh (Podlasek et al., 1
omeobox gene family, is expressed in the urogenital sinus epitheli
pithelial buds (Sciavolino et al., 1997). Homozygous mutant m
ranching morphogenesis (Bhatia-Gaur et al., 1999; Tanaka et a
pithelial and mesenchymal compartments of the male urogenital s
f mice with mutations in these Hox genes revealed multiple abno
ormation in the coagulating gland (Hoxa-13) and dorsal prostate
Hoxa-10), dorsal prostate (Hoxd-13 and Hoxa-13), and ventral prost
f prostate development are evident with compound Hoxa-13 androstate growth and glandular development (Podlasek et al.,
Copyright © 2001 by Academic Press. All right999a). The localization of Shh expression to the urogenital
epithelium of embryonic prostate (Podlasek et al., 1999a)
and of Bmp4 expression to the surrounding mesenchyme
ogenesis in the developing prostate. Bmp4 expression in the
nd is weaker at the apical tip. TGF-b1 is expressed predominantly
zed to mesenchyme surrounding emerging prostatic ducts (Timme
exhibit defects in prostate duct formation (cited in Abate-Shen and
pheral to the periurethral mesenchyme and distal to the elongating
explants in an in vitro organ culture (Thomson and Cunha, 1999).
ct localization in relation to the prostatic ducts is not yet known
testosterone (Sugimura et al., 1996; Thomson et al., 1997). Shh is
budding and antibody blockade of Shh function abrogates prostate
or Gli, a conserved target of Shh signaling, is expressed in the
; manuscript in preparation). Nkx3.1, a member of the murine Nkx
nd expression is localized to the distal edges of emerging prostatic
or Nkx3.1 exhibit prostatic epithelial hyperplasia and defective
00). Hoxd-13, Hoxa-13, and Hoxa-10 are expressed in both the
(Oefelein et al., 1996; Podlasek et al., 1999b,c). Phenotypic analysis
ities in male accessory sex organs including diminished main duct
d-13) and diminished ductal branching in the coagulating gland
oxa-13) (Podlasek et al., 1997, 1999b,c). More severe abnormalities
d-13 mutations (Warot et al., 1997).orph
uds a
ocali
d to
peri
tate
exa
e of
ctal
fact
999a
um a
ice f
l., 20
inus
rmal
(Hox
ate (H(present study) mirrors the Shh-Bmp4 pattern of expression
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313BMP4 Regulates Prostate Ductal Developmentat other sites of mesenchymal–epithelial interaction in the
developing embryo. While this colocalization has led to
speculations that Bmp4 is a downstream target of Shh
signaling (Bitgood and McMahon, 1995), Bmp4 expression
was maintained in the developmentally arrested hair fol-
licles of Shh2/2 mutant mouse embryos (St-Jacques et al.,
998). Our own (unpublished) observations seem to indicate
hat Bmp4 is not a direct downstream target gene of Shh
ignaling because antibody blockade of Shh signaling does
ot abolish Bmp4 expression in the developing mouse
rostate. However, this does not preclude an interaction
etween BMP4 and Shh signaling pathways in the regula-
ion of prostate development.
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